Adrenal myelolipoma: Difference between revisions

Jump to navigation Jump to search
(No difference)

Revision as of 21:08, 9 January 2009

Adrenal myelolipoma

WikiDoc Resources for Adrenal myelolipoma

Articles

Most recent articles on Adrenal myelolipoma

Most cited articles on Adrenal myelolipoma

Review articles on Adrenal myelolipoma

Articles on Adrenal myelolipoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Adrenal myelolipoma

Images of Adrenal myelolipoma

Photos of Adrenal myelolipoma

Podcasts & MP3s on Adrenal myelolipoma

Videos on Adrenal myelolipoma

Evidence Based Medicine

Cochrane Collaboration on Adrenal myelolipoma

Bandolier on Adrenal myelolipoma

TRIP on Adrenal myelolipoma

Clinical Trials

Ongoing Trials on Adrenal myelolipoma at Clinical Trials.gov

Trial results on Adrenal myelolipoma

Clinical Trials on Adrenal myelolipoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Adrenal myelolipoma

NICE Guidance on Adrenal myelolipoma

NHS PRODIGY Guidance

FDA on Adrenal myelolipoma

CDC on Adrenal myelolipoma

Books

Books on Adrenal myelolipoma

News

Adrenal myelolipoma in the news

Be alerted to news on Adrenal myelolipoma

News trends on Adrenal myelolipoma

Commentary

Blogs on Adrenal myelolipoma

Definitions

Definitions of Adrenal myelolipoma

Patient Resources / Community

Patient resources on Adrenal myelolipoma

Discussion groups on Adrenal myelolipoma

Patient Handouts on Adrenal myelolipoma

Directions to Hospitals Treating Adrenal myelolipoma

Risk calculators and risk factors for Adrenal myelolipoma

Healthcare Provider Resources

Symptoms of Adrenal myelolipoma

Causes & Risk Factors for Adrenal myelolipoma

Diagnostic studies for Adrenal myelolipoma

Treatment of Adrenal myelolipoma

Continuing Medical Education (CME)

CME Programs on Adrenal myelolipoma

International

Adrenal myelolipoma en Espanol

Adrenal myelolipoma en Francais

Business

Adrenal myelolipoma in the Marketplace

Patents on Adrenal myelolipoma

Experimental / Informatics

List of terms related to Adrenal myelolipoma

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Adrenal myelolipoma is a rare benign neoplasm. It is made up of mature adipose tissue and a variable amount of hematopoietic elements. Most lesions are small and asymptomatic. They are usually discovered incidentally at autopsy or on imaging studies performed for other reasons. Most tumors are unilateral but show no predilection to one particular side. Tumor size varies from several millimeters to more than 30 cm.

Epidemiology and Demographics

The incidence varies from 0.08-0.4% at autopsy.

Pathophysiology & Etiology

A myelolipoma may represent a site of extramedullary hematopoiesis. The most widely accepted theory is the existence of metaplasia of the reticuloendothelial cells of blood capillaries in the adrenal gland in response to stimuli such as necrosis, infection, or stress.

Template:SIB



Template:WikiDoc Sources